Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana M Gibb

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Treatment interruption in children with HIV infectionHannah Green, Diana M Gibb
The Lancet. Global Health|August 9, 2014
Sustainable and cost-effective monitoring of patients on ARTDiana M Gibb, Peter Mugyenyi
Current Opinion in Infectious Diseases|December 15, 2010
Monitoring of highly active antiretroviral therapy in HIV infectionA Sarah Walker, Diana M Gibb
Current Opinion in HIV and AIDS|April 18, 2009
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patientsAbdel G Babiker, Diana M Gibb
British Medical Bulletin|May 9, 2002
HIV disease and respiratory infection in childrenStephen M Graham, Diana M Gibb
Pediatrics|April 4, 2007
Increasing antiretroviral drug access for children with HIV infection, Peter L Havens, Diana M Gibb
The Lancet. Respiratory Medicine|September 27, 2019
Secondary re-analysis of the FEAST trialKathryn Maitland, Diana M Gibb, Abdel Babiker, et al.
The New England Journal of Medicine|June 22, 2022
Shorter Treatment for Tuberculosis in Children. ReplyAnna Turkova, Megan Palmer, Diana M Gibb
Current Opinion in Infectious Diseases|May 2, 2009
Management of paediatric HIV-1 resistanceRavindra K Gupta, Diana M Gibb, Deenan Pillay
Current Opinion in HIV and AIDS|November 20, 2013
Immediate antiretroviral therapy in young HIV-infected children: benefits and risksIntira J Collins, Ali Judd, Diana M Gibb
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Current Opinion in HIV and AIDS|April 18, 2009
Treatment interruption in children with HIV infectionHannah Green, Diana M Gibb
The Lancet. Global Health|August 9, 2014
Sustainable and cost-effective monitoring of patients on ARTDiana M Gibb, Peter Mugyenyi
Current Opinion in Infectious Diseases|December 15, 2010
Monitoring of highly active antiretroviral therapy in HIV infectionA Sarah Walker, Diana M Gibb
Current Opinion in HIV and AIDS|April 18, 2009
Considerations in the design of randomized controlled trials evaluating the optimal time to initiate antiretroviral therapy in previously untreated HIV-1-infected patientsAbdel G Babiker, Diana M Gibb
British Medical Bulletin|May 9, 2002
HIV disease and respiratory infection in childrenStephen M Graham, Diana M Gibb
Pediatrics|April 4, 2007
Increasing antiretroviral drug access for children with HIV infection, Peter L Havens, Diana M Gibb
The Lancet. Respiratory Medicine|September 27, 2019
Secondary re-analysis of the FEAST trialKathryn Maitland, Diana M Gibb, Abdel Babiker, et al.
The New England Journal of Medicine|June 22, 2022
Shorter Treatment for Tuberculosis in Children. ReplyAnna Turkova, Megan Palmer, Diana M Gibb
Current Opinion in Infectious Diseases|May 2, 2009
Management of paediatric HIV-1 resistanceRavindra K Gupta, Diana M Gibb, Deenan Pillay
Current Opinion in HIV and AIDS|November 20, 2013
Immediate antiretroviral therapy in young HIV-infected children: benefits and risksIntira J Collins, Ali Judd, Diana M Gibb
Pageof 25